A pragmatic, randomized clinical trial to evaluate the effect of a heart failure (HF) risk assessment and prevention strategy incorporating HF clinical risk scores (WATCH-DM) with cardiac biomarker (NT-proBNP) paired with a clinical decision support tool to implement an intensive prevention strategy among patients with high risk focused on implementation of evidence-based HF preventive therapies.
Primary Care Provider that sees diabetes patients in clinic
Provider does not see patients with Diabetes
University of Texas Southwestern Medical Center
Lead sponsor
Roche Diagnostics GmbH
Collaborator